This site is intended for healthcare professionals
Blue test tubes arranged in a line, disappearing into the background
  • Home
  • /
  • News
  • /
  • 2012
  • /
  • 04
  • /
  • FDA updates Victoza (Novo Nordisk) label to show s...
Drug news

FDA updates Victoza (Novo Nordisk) label to show superiority to Januvia

Read time: 1 mins
Last updated: 7th Apr 2012
Published: 7th Apr 2012
Source: Pharmawand
The FDA has approved to update the product label for Victoza (liraglutide [rDNA] injection) from Novo Nordisk to include data showing superior blood sugar control and weight reduction when compared to Januvia (sitagliptin0from Merck Inc,.
Type 2 Diabetes Learning Zone teaser tile
Type 2 Diabetes Learning Zone teaser tile
Learning Zone

Weight Management in Type 2 Diabetes

Explore the comorbidity risk of type 2 diabetes (T2D) and obesity, and the current management options available for T2D and weight loss

Read more
Learning Zone Homepage

Cardiovascular Metabolism Learning Zone

The cardiovascular metabolism (CVM) Learning Zone hosted on Medthority.com features over 70 expert opinion videos covering type 2 diabetes and hypertension.

Read more
How do you prefer to access medical updates and information?
CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Blue test tubes arranged in a line, disappearing into the background
Drug news
Moderna reports H5 Flu data
Moderna’s H5 flu vaccine shows strong immune response in Phase 1/2; HHS ends late-stage funding, new paths explored.
Read more
Drug news
Cibotercept in PAH ends

Published: 30th May 2025

Read more
Drug news
Khindivi cleared for pediatrics

Published: 30th May 2025

Read more
See all news